Today’s Watch List : SeaDrill Limited (NYSE:SDRL), GreenHunter Resources, Inc. (NYSEMKT:GRH), CTI BioPharma Corp. (NASDAQ:CTIC), Eli Lilly and Company (NYSE:LLY), TSLA

Wells Fargo & Co. reiterated their underperform rating on shares of Seadrill (NASDAQ:SDRL) in a research report released on Wednesday morning. SeaDrill Limited (NYSE:SDRL) shares fell -2.43% in last trading session and ended the day at $24.85. SDRL Gross Margin is 57.90% and its return on assets is 15.90%. SeaDrill Limited (NYSE:SDRL) quarterly performance is -36.51%. On Sep 16, GreenHunter Resources, Inc. (NYSEMKT:GRH), announced that … Continue reading Today’s Watch List : SeaDrill Limited (NYSE:SDRL), GreenHunter Resources, Inc. (NYSEMKT:GRH), CTI BioPharma Corp. (NASDAQ:CTIC), Eli Lilly and Company (NYSE:LLY), TSLA

Colin Pettis10/0310/03

Hot Stock List : CTI BioPharma (NASDAQ:CTIC), Verizon Communications (NYSE:VZ), Cogent Communications Holdings, Inc. (NASDAQ:CCOI), Chicago Bridge (NYSE:CBI), K12, Inc. (NYSE:LRN)

On July 28, 2014, CTI BioPharma Corp. (NASDAQ:CTIC) announced that it will report its second quarter 2014 financial results on Monday, August 4, 2014, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general corporate update at 4:30 p.m. EDT (1:30 p.m. PDT). CTI BioPharma … Continue reading Hot Stock List : CTI BioPharma (NASDAQ:CTIC), Verizon Communications (NYSE:VZ), Cogent Communications Holdings, Inc. (NASDAQ:CCOI), Chicago Bridge (NYSE:CBI), K12, Inc. (NYSE:LRN)

Jason Knox07/3107/31

Hot Movers: Prudential Public Limited Company (ADR) (NYSE:PUK), Cell Therapeutics Inc (NASDAQ:CTIC), Honda Motor Co (NYSE:HMC), General Motors Company (NYSE:GM)

Prudential Public Limited Company (ADR) (NYSE:PUK)’s shares slipped on Friday after the insurer was removed from the Americas Conviction Buy list at Goldman Sachs, which said there were better opportunities in the insurance and financial services sector. Goldman analyst Christopher Giovanni said he continues to view “PRU as one of the best opportunities in the space as its VA book trades at a discount vs. … Continue reading Hot Movers: Prudential Public Limited Company (ADR) (NYSE:PUK), Cell Therapeutics Inc (NASDAQ:CTIC), Honda Motor Co (NYSE:HMC), General Motors Company (NYSE:GM)

Jayne Crisman05/2705/27

Healthcare Bullish Stocks: Synta Pharmaceuticals (NASDAQ:SNTA), TherapeuticsMD Inc (NYSEMKT:TXMD), Cell Therapeutics Inc (NASDAQ:CTIC), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) announced that poster presentations related to studies with ganetespib, a selective Hsp90 inhibitor in clinical development by the company, and the company’s Hsp90 inhibitor drug conjugates (HDC) will be presented at the 2014 Annual Meeting of the American Association of Cancer Research in San Diego, California. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock performance was 10.07% in last session and finished the day … Continue reading Healthcare Bullish Stocks: Synta Pharmaceuticals (NASDAQ:SNTA), TherapeuticsMD Inc (NYSEMKT:TXMD), Cell Therapeutics Inc (NASDAQ:CTIC), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Colin Pettis04/1004/10

Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

U.S. health regulators on Friday approved a Celgene Corporation (NASDAQ:CELG) drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. Celgene Corporation (NASDAQ:CELG) stock performance was -3.74% in last session and finished the day at $144.40. Traded volume was 9.50million shares in the last session and the average volume of the stock remained … Continue reading Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

John Meady03/2403/24

Biotech Active Stocks: Pfizer Inc. (NYSE:PFE), Geron Corporation (NASDAQ:GERN), Cell Therapeutics (NASDAQ:CTIC), Chelsea Therapeutics International (NASDAQ:CHTP)

A US federal court yesterday invalidated Pfizer Inc.’s (NYSE:PFE) key patent covering its anti-inflammatory pill Celebrex. The patent, which was set to lapse in December 2015, would have given Pfizer an 18-month extension from the expiry of the patent for the major ingredient in the drug, celecoxib. Pfizer Inc. (NYSE:PFE) stock performance was -2.69% in last session and finished the day at $31.12. Traded volume … Continue reading Biotech Active Stocks: Pfizer Inc. (NYSE:PFE), Geron Corporation (NASDAQ:GERN), Cell Therapeutics (NASDAQ:CTIC), Chelsea Therapeutics International (NASDAQ:CHTP)

John Bellich03/1403/14